Clinical insights, sourcing guidance, and operational best practices for medical practices, med spas, and clinics building peptide fulfillment programs.
An informational comparison of FD&C Act sections 503A and 503B for licensed practices: who each applies to, patient-specific prescriptions versus outsourcing facilities, registration and oversight, with sources from FDA.
Read articleA provider-facing note on the CJC-1295 NO DAC + IPAMORELIN combined vial in the Biomed Peptides catalog: the 5/5 mg and 10/10 mg listings, an identity distinction between the two peptides, COA checks, and provider-only access.
Read articleA provider-facing explainer on the two GLOW 70 mg lyophilized vial listings in the Biomed Peptides catalog, the identity of each listed component, what to check on the COA, and provider-only access.
Read articleA provider-facing note on the KLOW 80 mg lyophilized vial in the Biomed Peptides catalog: how it is listed, why the COA and lot documentation define the contents, storage on receipt, and how licensed practices request access.
Read articleA provider-facing checklist for reading peptide vial labels on receipt: product name, strength, lot number and expiration, how to match them to the certificate of analysis, and how to keep lot records for traceability.
Read articleA provider-facing explainer on the DSIP peptide: its nine-residue sequence and 1977 origin, the nonproprietary name emideltide, where it appears on FDA's 503A pages, DSIP 5 mg and 10 mg lyophilized vials, COA documentation, and physician-use access.
Read articleHow licensed practices source glutathione for injection: the tripeptide's identity, reduced vs. oxidized forms, its place on FDA's 503A nominations list, lyophilized 600 mg and 1500 mg vials, storage, COA checks, and the factors behind glutathione injection price.
Read articleA provider-facing explainer on the LL-37 peptide: its 37-residue sequence and origin in the human CAMP gene, its classification as a cathelicidin antimicrobial peptide, where it appears on FDA's 503A pages, lyophilized 5 mg vial format, COA documentation, and physician-use access.
Read articleHow licensed practices source NAD+ for injection: the molecule's identity, where NAD and its salt forms sit on FDA's 503A nominations list, lyophilized 500 mg and 1000 mg vials, storage, NAD injection vs IV logistics, and how to evaluate a supplier.
Read articleA provider-facing explainer on the VIP peptide: what vasoactive intestinal peptide (VIP) is chemically, where it sits on FDA's 503A nominations list, how the lyophilized 10 mg vial is supplied and stored, and what documentation to request.
Read articleA provider-facing explainer on the Epitalon peptide (Ala-Glu-Asp-Gly): identity, origin, its 2026 regulatory context under FDA's 503A pages and HHS's peptide enforcement-discretion notice, lyophilized vial format, COA documentation, and physician-use access.
Read articleA provider-facing explainer on IGF-1 LR3: its 83-residue recombinant structure, how it differs from native IGF-1, lyophilized supply format, storage, COA documentation, and physician-use access.
Read articleHow licensed practices receive, store, organize, and label peptide vials: storage zones, peptide vial storage cases and vial cases, what a vial label maker should print, multi-dose dating, and COA record-keeping.
Read articleA provider-facing explainer on the Selank peptide: its seven-residue sequence, how it relates to tuftsin, where it appears on FDA's 503A pages, lyophilized vial format, COA documentation, and how licensed practices buy it.
Read articleA provider-facing explainer on the thymosin alpha 1 peptide: its 28-residue sequence and origin, where it stands on FDA's 503A nomination pages, lyophilized vial format, COA documentation, and physician-use access.
Read articleA look at BioAura Peptides as a retail peptide supplier: USA-made material, batch-specific HPLC and mass-spec testing, COAs on request, and how it relates to Biomed Peptides for licensed practices.
Read articleA provider-facing explainer on the CJC-1295 peptide, with emphasis on CJC-1295 No DAC as listed in the Biomed Peptides catalog, lyophilized supply format, and physician-use access.
Read articleA provider guide to choosing a medical peptide supplier: what high-quality peptides mean on paper (HPLC, MS, COAs, endotoxin), why provider-only access matters, and how Biomed Peptides serves practices.
Read articleA practical guide for licensed practices on reading a peptide COA, understanding third-party testing, and using lot documentation when you vet a supplier.
Read articleA provider-facing guide to working with a peptide compounding pharmacy: prescriptions, documentation, 503A basics, and how clinic lyophilized supply fits alongside compounding.
Read articleA clear contrast for medical practices: research-only chemicals labeled for laboratory use versus physician-use peptides supplied through verified provider channels and 503A compounding.
Read articleA provider-facing explainer on the SS-31 peptide: its tetrapeptide identity, the elamipretide synonym, lyophilized vial strengths, and how practices source physician-use supply.
Read article5-Amino-1MQ is usually listed with peptides, but chemically it's a small quinolinium compound. Here's what providers should know about its identity, vial format, and sourcing.
Read articleWhat bacteriostatic water for injection is, how it compares with preservative-free sterile water, and where it fits in a clinic's lyophilized peptide workflow.
Read articleA provider-facing explainer on the ipamorelin peptide: its pentapeptide sequence, its lyophilized vial format, and how licensed practices access physician-use supply.
Read articleA provider-facing explainer on the MOTS-c peptide: where its sequence comes from, how it ships as a lyophilized vial, and how practices access physician-use supply.
Read articleA provider-facing look at the TB-500 peptide: its seven-residue sequence, its relationship to thymosin beta-4, its lyophilized vial format, and how practices access it.
Read articleThe standard for lyophilized peptide storage is cold, dry, and dark. Here's a clinic-facing guide to storing peptide vials — temperature, light, moisture, freeze-thaw, and shelf life — based on manufacturer handling guidance.
Read articleLyophilized (freeze-dried) peptides explained for clinic staff — how they compare with non-lyophilized peptides, how to inspect a lyophilized vial, and how to reconstitute it with the right sterile diluent.
Read articleA practical checklist for vetting a peptide wholesale supplier — lot-specific COAs, endotoxin and sterility testing, regulatory pathway, API sourcing, cold-chain shipping, and provider-only account verification.
Read articleA provider's guide to 503A compounding pharmacies — what they are, how they differ from 503B outsourcing facilities, and what it means for sourcing compounded peptides.
Read articleWho can prescribe peptides? Federal law points to practitioners licensed by state law, and state scope-of-practice rules decide which clinicians — MDs, DOs, NPs, PAs — can prescribe, and under what supervision.
Read articleGLP-1 receptor agonists have reshaped medical weight management. Here is what providers should know about sourcing, handling, and dosing these in-demand therapies.
Read articleBPC-157 remains one of the most requested recovery peptides. Here's how to evaluate quality and integrate it into a clinically sound recovery protocol.
Read articleTemperature control is the invisible layer that protects peptide integrity. Here's what cold-chain fulfillment should look like for a clinical practice.
Read article